Franchisees opened 11 and closed 31 centers in fiscal 2025. System-wide sales of $947.3 million decreased 0.4% from $951.0 ...

BXCL501 demonstrated clinical benefits and favorable tolerability profile for treatment of opioid withdrawal symptoms Results from this NIDA-funded study support potential future development of ...

1. Background： With the increasing aging population, high incidence of chronic diseases, and the growing number of congenital or acquired foot deformities, lower limb dysfunction and abnormal gait ...